Search by Drug Name or NDC

    NDC 61874-0170-08 Vraylar Details

    Vraylar

    Vraylar is a ORAL KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is .

    Product Information

    NDC 61874-0170
    Product ID 61874-170_e342dd19-ed3b-4a30-b5ea-a17b3638e741
    Associated GPIs 5940001810B220
    GCN Sequence Number 075566
    GCN Sequence Number Description cariprazine HCl CAP DS PK 1.5 MG-3MG ORAL
    HIC3 H8W
    HIC3 Description ANTIPSYCHOTIC-ATYPICAL,D3/D2 PARTIAL AG-5HT MIXED
    GCN 40683
    HICL Sequence Number 042552
    HICL Sequence Number Description CARIPRAZINE HCL
    Brand/Generic Brand
    Proprietary Name Vraylar
    Proprietary Name Suffix n/a
    Non-Proprietary Name cariprazine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route ORAL
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Allergan, Inc.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA204370
    Listing Certified Through n/a

    Package

    NDC 61874-0170-08 (61874017008)

    NDC Package Code 61874-170-08
    Billing NDC 61874017008
    Package 1 BLISTER PACK in 1 CARTON (61874-170-08) / 1 KIT in 1 BLISTER PACK * 1 CAPSULE, GELATIN COATED in 1 BLISTER PACK * 6 CAPSULE, GELATIN COATED in 1 BLISTER PACK
    Marketing Start Date 2016-03-01
    NDC Exclude Flag N
    Pricing Information N/A